Conference Coverage: ASCO GI 2026 Highlights
Expert perspectives and strategic insights on the latest therapeutic developments in gastrointestinal (GI) cancer treatment from the 2026 ASCO GI Cancers Symposium.
January 23, 2026
FACULTY CHAIR
Tanios S. Bekaii-Saab, MD, FACP, FASCO
Mayo Clinic Cancer Center, Phoenix, AZ
Faculty Members
Gerald Prager, MD
Medical University of Vienna, Austria
Dirk Arnold, MD, PhD
Asklepios Tumorzentrum Hamburg, Germany
Eric Van Cutsem, MD, PhD
University Hospitals Leuven, Belgium
John Strickler, MD
Duke University Department of Medicine, Durham, NC, USA
Kristen Ciombor, MD
Vanderbilt University Medical Center, Nashville, TN, USA
Anthony El-Khoueiry, MD
USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA
KEY TAKEAWAYS
- Colorectal Cancer
– Systemic Therapy
– Biomarkers
- Hepatocellular Carcinoma
- Esophageal Cancers
- Gastric and Gastroesophageal Junction (GEJ) Cancers
- Pancreatic Cancer and Biliary Tract Cancer
